Cafepharma Today

February 11 2025 - Novartis inks $925M Anthos takeover to buy back phase 3 clot-busting candidate
Novartis inks $925M Anthos takeover to buy back phase 3 clot-busting candidate
Tariffs raise concern among generic drugmakers, as advocacy groups seek exemptions
Wegovy and Ozempic stars dim amid overuse concerns
Ten years on, Roche jettisons InterMune and Esbriet in US
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Mergers Bring New Challenges To Pharma
istockanalyst
Saturday, March 14, 2009 - 9:21am
tags:
Abbott’s Search for a Disappearing Stent
Wall Street Journal
Saturday, March 14, 2009 - 9:15am
tags:
Abbott Laboratories
Schering-Plough agrees to $165M legal settlement
Yahoo
Saturday, March 14, 2009 - 9:13am
tags:
Schering Plough
Department of Justice Declines to Intervene in False Claims Act Lawsuits Against Gilead Sciences
Yahoo
Saturday, March 14, 2009 - 9:10am
tags:
Gilead Sciences
Promise for Prostate Cancer Treatment?
CNBC
Saturday, March 14, 2009 - 9:09am
tags:
Cougar Biotechnology, prostate cancer
Is Roche Buying Genentech's Ills?
BusinessWeek
Saturday, March 14, 2009 - 9:07am
tags:
Roche, Genentech
Nanogen Receives NASDAQ Delisting Notice
Yahoo
Saturday, March 14, 2009 - 9:06am
tags:
Nanogen
Cytori Therapeutics Closes Previously Announced $10 Million Financing
Yahoo
Saturday, March 14, 2009 - 9:05am
tags:
Cytori
Dendreon Closing In On Provenge Profits
Forbes
Saturday, March 14, 2009 - 9:02am
tags:
Dendreon, Provenge
Pfizer CEO’s Compensation Slips 5% — to $13.1 Million
WSJ Online
Friday, March 13, 2009 - 3:29pm
tags:
Pfizer, Jeff Kindler, Pharma CEOs
A Lucky Friday The 13th For Merck
CNBC
Friday, March 13, 2009 - 3:28pm
tags:
Merck
Schering says anti-clotting drug met goal in trial
Yahoo/AP
Friday, March 13, 2009 - 3:27pm
tags:
Schering Plough, anti-clotting, drug trials
Is Bristol-Myers the Next Buyout?
Yahoo/Zacks.com
Friday, March 13, 2009 - 10:40am
tags:
Bristol-Myers Squibb, AstraZeneca, Sanofi, buyouts
Synta cuts 90 jobs, Glaxo deal in jeopardy
Bizjournals.com
Friday, March 13, 2009 - 10:38am
tags:
GSK, Synta, layoffs, elesclomol, melanoma
Vertex Pharmaceuticals Closes on Acquisition of ViroChem Pharma
Yahoo
Friday, March 13, 2009 - 9:40am
tags:
Vertex Pharmaceuticals, ViroChem, buyouts
Genentech timeline
San Francisco Chronicle, CA
Friday, March 13, 2009 - 9:30am
tags:
Genentech
Xoma loan may suffer Raptiva side effects
Bizjournals.com
Friday, March 13, 2009 - 9:28am
tags:
Xoma, Raptiva, Genentech
Genentech-Roche Deal Shows Attraction Of Biotech Assets
CNN Money
Friday, March 13, 2009 - 9:01am
tags:
Genentech, Roche, biotech, buyouts
J&J $3 Billion Drug Duel Looms in Schering’s Merger
Bloomberg
Friday, March 13, 2009 - 8:59am
tags:
Merck, JNJ, Schering Plough, Remicade, buyouts
Big Mergers Could Mean Sweet Gains for Biotech
Seeking Alpha
Friday, March 13, 2009 - 8:57am
tags:
biotech, Amgen, Gilead Sciences, CV Therapeutics, Biogen Idec, Genzyme, Biomarin, Medivation

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

The Continuing NIH/NSF Crisis, Part III: Indirect Costs
In the Pipeline
Vaccines Through Protein Degradation
In the Pipeline
Today’s Rare Disease Launches Require the Right Specialty Pharmacy Partner
Drug Channels
An Evaluation of "Deep Research" Performance
In the Pipeline
The Continuing NIH/NSF Crisis, Part II
In the Pipeline
Revised and Extended: What's Happening Inside the NIH and NSF
In the Pipeline
What's Happening Inside the NIH and NSF
In the Pipeline
Vertical Integration Redux: How Pharmaceutical Wholesalers Are Transforming the Buy-and-Bill Market (Video)
Drug Channels
Informa Connect's Access USA
Drug Channels

Latest Jobs

Cell Therapy Navigator
Houston, Texas, 77002
Inizio Engage
Rapid Deployment Representative
Fort Worth, Texas, 76102
Inizio Engage
Rapid Deployment Representative
Charlotte, North Carolina, 28245
Inizio Engage
Oncology Key Account Manager
Newark, New Jersey, 07175
Inizio Engage
Cell Therapy Navigator
Little Rock, Arkansas, 72208
Inizio Engage
Territory Business Manager
Philadelphia, Pennsylvania, 19107
Inizio Engage
Business Development Representative
Las Vegas, Nevada, 89105
Professional Case Management
Oncology Key Account Manager
Atlanta, Georgia, 30383
Inizio Engage
Territory Manager, Surgical Pain - South Houston, TX
TX,
Avanos Medical
Neurology Account Manager- MD/DC/N VA (Remote)
Annapolis, Maryland, 21401
Jazz Pharmaceuticals
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information